Acorah Software Products - Accounts Production 16.8.200 false true false true No description of principal activity 1 May 2024 30 April 2025 30 April 2025 15693495 Dr James Claypole iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15693495 2024-04-30 15693495 2025-04-30 15693495 2024-05-01 2025-04-30 15693495 frs-core:CurrentFinancialInstruments 2025-04-30 15693495 frs-core:Non-currentFinancialInstruments 2025-04-30 15693495 frs-bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 15693495 frs-bus:FilletedAccounts 2024-05-01 2025-04-30 15693495 frs-bus:Micro-entities 2024-05-01 2025-04-30 15693495 frs-bus:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 15693495 frs-bus:Director1 2024-05-01 2025-04-30
Registered number: 15693495
Ailarian Ltd
Unaudited Financial Statements
For The Year Ended 30 April 2025
Contents
Page
Statement of Financial Position 1
Page 1
Statement of Financial Position
Registered number: 15693495
2025
£
Fixed assets 81,745
Current assets 99,269
Creditors: Amounts Falling Due Within One Year (26,761 )
NET CURRENT ASSETS 72,508
TOTAL ASSETS LESS CURRENT LIABILITIES 154,253
Creditors: Amounts Falling Due After More Than One Year (27,877 )
NET ASSETS 126,376
CAPITAL AND RESERVES 126,376

Notes

1. General Information
Ailarian Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15693495 . The registered office is 25 Iorwerth Street, Manselton, Swansea, SA5 9NP.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 5
5
For the year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr James Claypole
Director
8th January 2026